指南与共识间质性肺疾病肺栓塞与肺血管病

间质性肺疾病患者肺动脉高压筛查策略:多学科德尔菲研究

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.
指南 / 共识 · Chest · 2022-02-15

该研究采用改良德尔菲共识流程,由16名肺动脉高压(PH)与间质性肺疾病(ILD)领域的呼吸科专家参与三轮调查,旨在明确ILD患者中PH的筛查策略。专家共识确定了疑诊PH的多个触发因素、筛查工具(超声心动图和BNP/NT-proBNP)以及右心导管确诊的必要性,为临床及时识别和转诊提供指导。

要点

  • 症状、体征、胸部CT或影像异常、脉搏血氧饱和度异常、BNP/NT-proBNP升高及肺功能或6分钟步行距离不明原因恶化均提示疑诊PH。
  • 超声心动图和BNP/NT-proBNP被确定为PH筛查工具,右心导管是确诊PH的必要方法。
  • 因缺乏标准化方案,该共识旨在帮助医生识别ILD合并可能的PH并指导及时行右心导管检查。

核心结论

  • 许多ILD患者可能受益于PH的早期评估,因为已有获批疗法可用。
  • 该共识声明旨在帮助医生识别ILD合并可能的PH,并指导及时行右心导管检查。

研究设计与样本

  • 研究召集了16名在PH和ILD方面具有专长的呼吸科医生组成专家组。
  • 采用改良德尔菲共识流程,通过三轮调查确定PH筛查策略。
  • 第一轮调查主要由开放式问题组成,第二轮和第三轮调查基于第一轮回答制定,包含关于PH筛查的陈述,由专家按-5(强烈不同意)到5(强烈同意)评分。

主要发现

  • 专家就疑诊PH的多个触发因素达成共识,包括症状、临床体征、胸部CT或其他影像学发现、脉搏血氧饱和度异常、BNP或NT-proBNP升高以及肺功能检查或6分钟步行距离的不明原因恶化。
  • 超声心动图和BNP/NT-proBNP被确定为PH的筛查工具。
  • 右心导管检查被认为对确诊PH至关重要。

关键数值与推荐

  • 专家共识支持对ILD患者中出现的症状、临床体征、胸部CT或其他影像学发现、脉搏血氧饱和度异常、BNP或NT-proBNP升高以及肺功能检查或6分钟步行距离不明原因恶化等情况怀疑PH。
  • 超声心动图和BNP/NT-proBNP被确定为PH筛查工具。
  • 右心导管检查被认为对确诊PH至关重要。

临床怎么用

  • 临床医生应关注ILD患者中提示PH的触发因素,如症状、体征、影像学异常、脉搏血氧饱和度异常、BNP/NT-proBNP升高及肺功能或6分钟步行距离不明原因恶化。
  • 对疑诊PH的ILD患者可使用超声心动图和BNP/NT-proBNP进行筛查。
  • 确诊PH需行右心导管检查,对疑诊患者应及时转诊行右心导管检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary hypertension (PH) is a common complication of interstitial lung disease (ILD) and is associated with worse outcomes and increased mortality. Evaluation of PH is recommended in lung transplant candidates, but there are currently no standardized screening approaches. Trials have identified therapies that are effective in this setting, providing another rationale to routinely screen patients with ILD for PH. RESEARCH QUESTION: What screening strategies for identifying PH in patients with ILD are supported by expert consensus? STUDY DESIGN AND METHODS: The study convened a panel of 16 pulmonologists with expertise in PH and ILD, and used a modified Delphi consensus process with three surveys to identify PH screening strategies. Survey 1 consisted primarily of open-ended questions. Surveys 2 and 3 were developed from responses to survey 1 and contained statements about PH screening that panelists rated from -5 (strongly disagree) to 5 (strongly agree). RESULTS: Panelists reached consensus on several triggers for suspicion of PH including the following: symptoms, clinical signs, findings on chest CT scan or other imaging, abnormalities in pulse oximetry, elevations in brain natriuretic peptide (BNP) or N-terminal pro-brain natriuretic peptide (NT-proBNP), and unexplained worsening in pulmonary function tests or 6-min walk distance. Echocardiography and BNP/NT-proBNP were identified as screening tools for PH. Right heart catheterization was deemed essential for confirming PH. INTERPRETATION: Many patients with ILD may benefit from early evaluation of PH now that an approved therapy is available. Protocols to evaluate patients with ILD often overlap with evaluations for pulmonary hypertension-interstitial lung disease and can be used to assess the risk of PH. Because standardized approaches are lacking, this consensus statement is intended to aid physicians in the identification of patients with ILD and possible PH, and provide guidance for timely right heart catheterization.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Rahaghi FF, Kolaitis NA, Adegunsoye A, et al. Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. Chest. 2022. PMID: 35176276. doi:10.1016/j.chest.2022.02.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。